Changes are coming to our lives and world that may rival the industrial and internet revolutions. Jeremy Schwartz and Kara Marciscano discuss the BioRevolution already underway and identify the range of business sectors we believe are best positioned to benefit.
In the conclusion to our series addressing common misconceptions about ETFs and smart beta, we touch on the myth of ETFs causing systematic issues due to their illiquidity.
Quantitative easing liquidity world average correlations have been dropping in the U.S., and we see similar patterns globally, especially in Europe and Japan. How should investors account for this when constructing their portfolios?
The third part of our four-part series addressing common misconceptions about ETFs and smart beta covers supposed data mining in smart beta.
In the first part of our series addressing common misconceptions about ETFs and smart beta, we discuss the supposed academic consensus that the only recourse for investors frustrated with active management is to turn to market capitalization-weighted index funds.
